Skip to content
Medical Health Aged Care, National News Current Affairs

Dental peak body responds to Greens’ super clinics announcement

Australian Dental Association < 1 min read

4.10.24

 

 

 

Dental peak body responds to Greens’ super clinics announcement

 

The Greens’ announcement that it wants the Labor Government to set up 1,000 super clinics staffed by dentists, doctors and other health practitioners if it wants Greens’ support in the event of a hung parliament, has the Australian Dental Association (ADA) questioning how practical the plan is.

With each facility to be staffed by 25 healthcare workers, the clinics would offer free healthcare and need to attract around one in ten dentists currently practicing elsewhere.

“While the ADA thinks the idea has merit in principle, as ever the devil is in the detail including actually securing the $54 billion over a decade to fund this,” said ADA President Dr Scott Davis.

“There are questions around budgetary prioritisation because Labor has signalled fairly consistently that it won’t be increasing federal funding for dental treatment any time soon.

“To staff the proposed clinics with existing dentists would require attracting them away from existing clinics, or training a very significant number of new dentists, which takes time and is subject to constraints. So it might be a challenge to make strong headway on this within the term of the next government.

“While the plan has merit, it needs more careful consideration around how the super clinics  would be staffed and funded, and the ADA is happy to sit down with political parties to help them work through practical, publicly funded dental policy options.”

Ends.

 

To interview ADA President Dr Scott Davis, call ADA Federal Media Advisor

Jenny Barlass on 0497 748 331.

 

 

 

 

 

 

 

 

 

 


Contact details:

Jenny Barlass Federal Media Advisor 0497 748 331

Media

More from this category

  • Medical Health Aged Care
  • 21/05/2026
  • 22:17
Merck

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority…

  • Contains:
  • Medical Health Aged Care
  • 21/05/2026
  • 21:18
Baszucki Group

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

Randomized controlled trial will evaluate both symptom progression and underlying biology SAN MATEO, Calif.–BUSINESS WIRE– Baszucki Group today announced a £1.17 million grant to…

  • Contains:
  • Medical Health Aged Care
  • 21/05/2026
  • 20:47
Sinovac Biotech Ltd.

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.